PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-166.34%
Both yoy net incomes decline, with CRK at -33.98%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
0.97%
Less D&A growth vs. CRK's 119.53%, reducing the hit to reported earnings. David Dodd would confirm that core assets remain sufficient.
98.45%
Some yoy growth while CRK is negative at -135.92%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-9.09%
Negative yoy SBC while CRK is 6.45%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
138.60%
Well above CRK's 69.42% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
42.17%
AR growth while CRK is negative at -371.53%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-120.00%
Negative yoy inventory while CRK is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-37.70%
Negative yoy AP while CRK is 356.55%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
338.89%
Growth well above CRK's 508.85%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
3010.00%
Some yoy increase while CRK is negative at -20.84%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-9.31%
Both yoy CFO lines are negative, with CRK at -0.50%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-9.43%
Both yoy lines negative, with CRK at -4.39%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
102000.00%
Some acquisitions while CRK is negative at -94.50%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-350.00%
Both yoy lines negative, with CRK at -94.50%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
276.95%
We have mild expansions while CRK is negative at -4.51%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-144.72%
We cut debt repayment yoy while CRK is 22.20%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.